vs
Airsculpt Technologies, Inc.（AIRS）与湘南美容医疗集团（SBC）财务数据对比。点击上方公司名可切换其他公司
湘南美容医疗集团的季度营收约是Airsculpt Technologies, Inc.的1.2倍（$39.6M vs $33.4M）。湘南美容医疗集团净利率更高（35.9% vs 3.8%，领先32.1%）。湘南美容医疗集团同比增速更快（-10.9% vs -14.6%）。湘南美容医疗集团自由现金流更多（$51.2M vs $-2.6M）。过去两年湘南美容医疗集团的营收复合增速更高（-15.0% vs -16.2%）
Airsculpt Technologies是一家医疗科技与医美服务提供商，主打自有专利的AirSculpt微创身体塑形项目。公司在美国各地运营高端诊所，为寻求精准减脂、塑形服务的消费者提供恢复期远短于传统医美手术的高端门诊美容护理。
湘南美容医疗集团是总部位于日本的知名医疗服务提供商，核心业务覆盖美容整形、皮肤科诊疗、抗衰老健康护理等领域，在日本各地运营大量连锁诊所，同时服务本地居民及赴日就医的国际游客。
AIRS vs SBC — 直观对比
营收规模更大
SBC
是对方的1.2倍
$33.4M
营收增速更快
SBC
高出3.7%
-14.6%
净利率更高
SBC
高出32.1%
3.8%
自由现金流更多
SBC
多$53.8M
$-2.6M
两年增速更快
SBC
近两年复合增速
-16.2%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $33.4M | $39.6M |
| 净利润 | $1.3M | $14.2M |
| 毛利率 | — | 73.1% |
| 营业利润率 | -3.0% | 32.5% |
| 净利率 | 3.8% | 35.9% |
| 营收同比 | -14.6% | -10.9% |
| 净利润同比 | 126.7% | 117.2% |
| 每股收益（稀释后） | $0.02 | $0.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AIRSSBC
| Q4 25 | $33.4M | $39.6M | ||
| Q3 25 | $35.0M | $43.4M | ||
| Q2 25 | $44.0M | $43.4M | ||
| Q1 25 | $39.4M | $47.3M | ||
| Q4 24 | $39.2M | $44.4M | ||
| Q3 24 | $42.5M | $53.1M | ||
| Q2 24 | $51.0M | $53.1M | ||
| Q1 24 | $47.6M | $54.8M |
净利润AIRSSBC
| Q4 25 | $1.3M | $14.2M | ||
| Q3 25 | $-9.5M | $12.8M | ||
| Q2 25 | $-591.0K | $2.5M | ||
| Q1 25 | $-2.8M | $21.5M | ||
| Q4 24 | $-4.8M | $6.5M | ||
| Q3 24 | $-6.0M | $2.8M | ||
| Q2 24 | $-3.2M | $18.5M | ||
| Q1 24 | $6.0M | $18.8M |
毛利率AIRSSBC
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
营业利润率AIRSSBC
| Q4 25 | -3.0% | 32.5% | ||
| Q3 25 | -27.9% | 36.6% | ||
| Q2 25 | 1.8% | 33.6% | ||
| Q1 25 | -4.0% | 51.1% | ||
| Q4 24 | -9.9% | 10.6% | ||
| Q3 24 | -8.7% | 26.1% | ||
| Q2 24 | -9.8% | 51.4% | ||
| Q1 24 | 23.1% | 44.6% |
净利率AIRSSBC
| Q4 25 | 3.8% | 35.9% | ||
| Q3 25 | -27.2% | 29.6% | ||
| Q2 25 | -1.3% | 5.7% | ||
| Q1 25 | -7.2% | 45.4% | ||
| Q4 24 | -12.3% | 14.7% | ||
| Q3 24 | -14.2% | 5.3% | ||
| Q2 24 | -6.3% | 34.8% | ||
| Q1 24 | 12.7% | 34.2% |
每股收益（稀释后）AIRSSBC
| Q4 25 | $0.02 | $0.15 | ||
| Q3 25 | $-0.15 | $0.12 | ||
| Q2 25 | $-0.01 | $0.02 | ||
| Q1 25 | $-0.05 | $0.21 | ||
| Q4 24 | $-0.08 | $0.05 | ||
| Q3 24 | $-0.10 | $0.03 | ||
| Q2 24 | $-0.06 | $0.20 | ||
| Q1 24 | $0.10 | $0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.4M | $164.1M |
| 总债务越低越好 | $56.0M | $42.8M |
| 股东权益账面价值 | $87.7M | $248.3M |
| 总资产 | $187.3M | $380.4M |
| 负债/权益比越低杠杆越低 | 0.64× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资AIRSSBC
| Q4 25 | $8.4M | $164.1M | ||
| Q3 25 | $5.4M | $127.4M | ||
| Q2 25 | $8.2M | $152.7M | ||
| Q1 25 | $5.6M | $132.1M | ||
| Q4 24 | $8.2M | $125.0M | ||
| Q3 24 | $6.0M | $137.4M | ||
| Q2 24 | $9.9M | — | ||
| Q1 24 | $11.0M | — |
总债务AIRSSBC
| Q4 25 | $56.0M | $42.8M | ||
| Q3 25 | $56.9M | $21.1M | ||
| Q2 25 | $57.7M | $7.1M | ||
| Q1 25 | $68.5M | $6.9M | ||
| Q4 24 | $69.7M | $6.6M | ||
| Q3 24 | $70.1M | $823.2K | ||
| Q2 24 | $70.7M | — | ||
| Q1 24 | $71.2M | — |
股东权益AIRSSBC
| Q4 25 | $87.7M | $248.3M | ||
| Q3 25 | $82.1M | $248.0M | ||
| Q2 25 | $91.2M | $244.6M | ||
| Q1 25 | $77.3M | $226.4M | ||
| Q4 24 | $78.2M | $195.1M | ||
| Q3 24 | $82.5M | $205.0M | ||
| Q2 24 | $85.0M | $8.8M | ||
| Q1 24 | $83.5M | $9.0M |
总资产AIRSSBC
| Q4 25 | $187.3M | $380.4M | ||
| Q3 25 | $185.9M | $321.4M | ||
| Q2 25 | $198.4M | $315.3M | ||
| Q1 25 | $203.3M | $284.6M | ||
| Q4 24 | $212.8M | $266.1M | ||
| Q3 24 | $208.2M | $296.5M | ||
| Q2 24 | $210.1M | $19.5M | ||
| Q1 24 | $202.7M | $19.8M |
负债/权益比AIRSSBC
| Q4 25 | 0.64× | 0.17× | ||
| Q3 25 | 0.69× | 0.09× | ||
| Q2 25 | 0.63× | 0.03× | ||
| Q1 25 | 0.89× | 0.03× | ||
| Q4 24 | 0.89× | 0.03× | ||
| Q3 24 | 0.85× | 0.00× | ||
| Q2 24 | 0.83× | — | ||
| Q1 24 | 0.85× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.5M | $52.0M |
| 自由现金流经营现金流 - 资本支出 | $-2.6M | $51.2M |
| 自由现金流率自由现金流/营收 | -7.7% | 129.3% |
| 资本支出强度资本支出/营收 | 0.2% | 2.0% |
| 现金转化率经营现金流/净利润 | -1.97× | 3.66× |
| 过去12个月自由现金流最近4个季度 | $692.0K | $23.3M |
8季度趋势，按日历期对齐
经营现金流AIRSSBC
| Q4 25 | $-2.5M | $52.0M | ||
| Q3 25 | $-225.0K | $-20.9M | ||
| Q2 25 | $5.0M | $-8.3M | ||
| Q1 25 | $868.0K | $1.9M | ||
| Q4 24 | $2.7M | $-7.3M | ||
| Q3 24 | $1.8M | $5.0M | ||
| Q2 24 | $3.4M | $19.2M | ||
| Q1 24 | $3.4M | $3.7M |
自由现金流AIRSSBC
| Q4 25 | $-2.6M | $51.2M | ||
| Q3 25 | $-405.0K | $-20.9M | ||
| Q2 25 | $4.7M | $-8.6M | ||
| Q1 25 | $-1.0M | $1.7M | ||
| Q4 24 | $-815.0K | $-7.9M | ||
| Q3 24 | $-3.1M | $4.6M | ||
| Q2 24 | $-576.0K | $18.3M | ||
| Q1 24 | $1.8M | $3.0M |
自由现金流率AIRSSBC
| Q4 25 | -7.7% | 129.3% | ||
| Q3 25 | -1.2% | -48.3% | ||
| Q2 25 | 10.7% | -19.9% | ||
| Q1 25 | -2.6% | 3.5% | ||
| Q4 24 | -2.1% | -17.8% | ||
| Q3 24 | -7.2% | 8.7% | ||
| Q2 24 | -1.1% | 34.5% | ||
| Q1 24 | 3.8% | 5.4% |
资本支出强度AIRSSBC
| Q4 25 | 0.2% | 2.0% | ||
| Q3 25 | 0.5% | 0.1% | ||
| Q2 25 | 0.6% | 0.7% | ||
| Q1 25 | 4.8% | 0.5% | ||
| Q4 24 | 9.0% | 1.3% | ||
| Q3 24 | 11.5% | 0.8% | ||
| Q2 24 | 7.9% | 1.6% | ||
| Q1 24 | 3.3% | 1.3% |
现金转化率AIRSSBC
| Q4 25 | -1.97× | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | 0.56× | 0.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AIRS
暂无分部数据
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
